Cosmos Health (COSM) closed at $0.30 on November 6, 2026, up 5.1% from the previous close, on volume of 918,699 shares (30-day average 2,701,841).
Data as of November 6, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 23, 2026 | Call Spread | 16-Apr-270.5 : 1 C | 206 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
ACCESS Newswire (Thu, 5-Nov 8:00 AM ET)
ACCESS Newswire (Wed, 4-Nov 9:27 AM ET)
Cosmos Health's U.S. Active Subscriptions Surpass 12,000, Up 92% in Two Weeks
ACCESS Newswire (Thu, 29-Oct 9:23 AM ET)
ACCESS Newswire (Wed, 28-Oct 9:20 AM ET)
ACCESS Newswire (Thu, 22-Oct 3:55 PM ET)
ACCESS Newswire (Tue, 20-Oct 12:15 PM ET)
ACCESS Newswire (Mon, 19-Oct 9:30 AM ET)
ACCESS Newswire (Wed, 14-Oct 9:30 AM ET)
ACCESS Newswire (Tue, 13-Oct 9:30 AM ET)
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
Cosmos Health trades on the NASDAQ stock market under the symbol COSM.
As of November 9, 2026, COSM stock price declined to $0.27 with 1,183,888 million shares trading.
COSM has a beta of 2.74, meaning it tends to be more sensitive to market movements. COSM has a correlation of 0.12 to the broad based SPY ETF.
COSM has a market cap of $27.17 million. This is considered a Sub-Micro Cap stock.
Last quarter Cosmos Health reported $19 million in Revenue and -$.10 earnings per share. This fell short of revenue expectation by $-434,136 and missed earnings estimates by -$.11.
In the last 3 years, COSM traded as high as $1.65 and as low as $.16.
The top ETF exchange traded funds that COSM belongs to (by Net Assets): VXF.
COSM has underperformed the market in the last year with a return of -59.9%, while SPY returned +13.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in COSM shares. However, COSM has outperformed the market in the last 3 month and 2 week periods, returning +22.2% and +3.4%, while SPY returned -1.9% and -1.0%, respectively. This indicates COSM has been having a stronger performance recently.
COSM support price is $.28 and resistance is $.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COSM shares will trade within this expected range on the day.
